Detalhe da pesquisa
1.
Identifying Epistasis in Cancer Genomes: A Delicate Affair.
Cell
; 177(6): 1375-1383, 2019 05 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-31150618
2.
Estrogen receptor 1 chromatin profiling in human breast tumors reveals high inter-patient heterogeneity with enrichment of risk SNPs and enhancer activity at most-conserved regions.
Genome Res
; 34(4): 539-555, 2024 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38719469
3.
Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk.
Am J Hum Genet
; 107(5): 837-848, 2020 11 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33022221
4.
Transcriptome-wide association study of breast cancer risk by estrogen-receptor status.
Genet Epidemiol
; 44(5): 442-468, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32115800
5.
Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment.
Breast Cancer Res
; 23(1): 86, 2021 08 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34407845
6.
Radiogenomic Analysis of Breast Cancer by Linking MRI Phenotypes with Tumor Gene Expression.
Radiology
; 296(2): 277-287, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32452738
7.
Breast cancer risk factors and their effects on survival: a Mendelian randomisation study.
BMC Med
; 18(1): 327, 2020 11 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33198768
8.
Genome-wide association study of germline variants and breast cancer-specific mortality.
Br J Cancer
; 120(6): 647-657, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30787463
9.
Molecular characterization of breast and lung tumors by integration of multiple data types with functional sparse-factor analysis.
PLoS Comput Biol
; 14(10): e1006520, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30379847
10.
Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression.
Am J Hum Genet
; 97(1): 22-34, 2015 Jul 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-26073781
11.
Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1.
Am J Hum Genet
; 96(1): 5-20, 2015 Jan 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-25529635
12.
Fine-scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer.
Int J Cancer
; 139(6): 1303-1317, 2016 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27087578
13.
Common germline polymorphisms associated with breast cancer-specific survival.
Breast Cancer Res
; 17: 58, 2015 Apr 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-25897948
14.
Oestrogen receptor-co-factor-chromatin specificity in the transcriptional regulation of breast cancer.
EMBO J
; 30(23): 4764-76, 2011 Oct 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-22002538
15.
Breast cancer risk SNPs converge on estrogen receptor binding sites commonly shared between breast tumors to locally alter estrogen signalling output.
bioRxiv
; 2023 Nov 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37961147
16.
Differential Survival and Therapy Benefit of Patients with Breast Cancer Are Characterized by Distinct Epithelial and Immune Cell Microenvironments.
Clin Cancer Res
; 28(5): 960-971, 2022 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34965952
17.
Association of the germline TP53 R72P and MDM2 SNP309 variants with breast cancer survival in specific breast tumor subgroups.
Breast Cancer Res Treat
; 130(2): 599-608, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-21667122
18.
Contralateral parenchymal enhancement on MRI is associated with tumor proteasome pathway gene expression and overall survival of early ER+/HER2-breast cancer patients.
Breast
; 60: 230-237, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34763270
19.
Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis.
Sci Rep
; 11(1): 19787, 2021 10 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34611289
20.
Integrative analysis of genomic amplification-dependent expression and loss-of-function screen identifies ASAP1 as a driver gene in triple-negative breast cancer progression.
Oncogene
; 39(20): 4118-4131, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32235890